Actively Recruiting
Pelvis Adaptive Radiotherapy (ART)
Led by Royal North Shore Hospital · Updated on 2026-02-05
280
Participants Needed
1
Research Sites
320 weeks
Total Duration
On this page
Sponsors
R
Royal North Shore Hospital
Lead Sponsor
N
Northern Sydney and Central Coast Area Health Service
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pelvis Adaptive radiotherapy (ART) is a two phase study looking at using adaptive radiotherapy to help reduce toxicity for cancer patients having radiotherapy in the pelvic region. Adaptive radiotherapy is a new technology that provides the ability to account for daily changes in anatomy. Adaptive radiotherapy also provides a foundation for which radiotherapy margins might be safely reduced. Phase 1 of this study is looking to see if a radiation therapist centred adaptive workflow can be implemented. If phase 1 of this study is safe and feasible, the study will proceed to phase 2. Phase 2 of the study looks at using adaptive technology to reduce radiation treatment margins. The primary aim of this study is to see whether margin reduced treatment using adaptive radiotherapy can reduce side effects for patients with cancer in the pelvic area.
CONDITIONS
Official Title
Pelvis Adaptive Radiotherapy (ART)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18
- ECOG performance status 0-2
- Patients receiving curative or adjuvant pelvic radiation including prostate cancer with nodal treatment, post prostatectomy, bladder cancer, rectal cancer, anal cancer, adjuvant radiotherapy for gynecological cancers, or pelvic lymph nodes only
- Ability to understand and willing to sign informed consent
You will not qualify if you...
- Presence of hip prosthesis
- Patient separation from radiation center to skin edge > 24 cm measured on diagnostic scan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Northern Sydney Local Health District
St Leonards, New South Wales, Australia, 2065
Actively Recruiting
Research Team
N
Nada Cheikh-Ali
CONTACT
H
Heidi Tsang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here